ExcelMale
Menu
Home
What's new
Latest activity
Forums
New posts
Search forums
What's new
New posts
Latest activity
Videos
Lab Tests
Doctor Finder
Buy Books
About Us
Men’s Health Coaching
Log in
Register
What's new
Search
Search
Search titles only
By:
New posts
Search forums
Menu
Log in
Register
Navigation
Install the app
Install
More options
Contact us
Close Menu
Forums
Testosterone Replacement, Low T, HCG, & Beyond
Testosterone and Men's Health Articles
Acerus Announces Significant Improvement in NATESTO® Insurance Coverage in the United States
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Reply to thread
Message
<blockquote data-quote="madman" data-source="post: 179627" data-attributes="member: 13851"><p><span style="color: rgb(184, 49, 47)">Jun 03, 2020 07:00 am</span></p><p></p><p>[URL unfurl="true"]https://www.businesswire.com/news/home/20200603005230/en/[/URL]</p><p></p><p><strong>TORONTO --</strong></p><p></p><p>Acerus Pharmaceuticals Corporation (TSX:ASP, OTCQB:ASPCF), a specialty pharmaceutical company focused on the commercialization of novel prescription products in Men’s Health, <strong><em><span style="color: rgb(184, 49, 47)">today announced that, as of July 1, 2020, Express Scripts, Inc., one of the leading pharmacy benefit managers (PBMs) in the United States, </span><span style="color: rgb(44, 130, 201)">has elected to make NATESTO® (testosterone nasal gel) a preferred brand on its National Preferred Drug List.</span></em></strong></p><p></p><p>"This formulary placement by Express Scripts is a significant milestone in Acerus’ commercial efforts in the United States,” said Ed Gudaitis, President and Chief Executive Officer of Acerus.<span style="color: rgb(184, 49, 47)"> <strong><em>“Within 10 weeks of the implementation of Acerus’ market access efforts, NATESTO® has been added as Preferred on the Express Scripts National Preferred formulary.</em></strong> </span><span style="color: rgb(44, 130, 201)"><strong><em>We believe this improved coverage will enhance patient access and increase physician’s prescribing of NATESTO® for the more than 13 million U.S. men diagnosed with hypogonadism."</em></strong></span></p><p></p><p>Express Scripts serves more than 3,000 clients covering 70 million lives, including approximately 9 million lives managed by Cigna HealthCare. Drugs listed on formulary as preferred brands have been evaluated by the pharmacy benefit manager from a therapeutic and value perspective. <span style="color: rgb(184, 49, 47)"><em><strong>Preferred brand drugs may be available to patients at a lower co-pay or co-insurance than non-preferred brand drugs.</strong></em></span></p></blockquote><p></p>
[QUOTE="madman, post: 179627, member: 13851"] [COLOR=rgb(184, 49, 47)]Jun 03, 2020 07:00 am[/COLOR] [URL unfurl="true"]https://www.businesswire.com/news/home/20200603005230/en/[/URL] [B]TORONTO --[/B] Acerus Pharmaceuticals Corporation (TSX:ASP, OTCQB:ASPCF), a specialty pharmaceutical company focused on the commercialization of novel prescription products in Men’s Health, [B][I][COLOR=rgb(184, 49, 47)]today announced that, as of July 1, 2020, Express Scripts, Inc., one of the leading pharmacy benefit managers (PBMs) in the United States, [/COLOR][COLOR=rgb(44, 130, 201)]has elected to make NATESTO® (testosterone nasal gel) a preferred brand on its National Preferred Drug List.[/COLOR][/I][/B] "This formulary placement by Express Scripts is a significant milestone in Acerus’ commercial efforts in the United States,” said Ed Gudaitis, President and Chief Executive Officer of Acerus.[COLOR=rgb(184, 49, 47)] [B][I]“Within 10 weeks of the implementation of Acerus’ market access efforts, NATESTO® has been added as Preferred on the Express Scripts National Preferred formulary.[/I][/B] [/COLOR][COLOR=rgb(44, 130, 201)][B][I]We believe this improved coverage will enhance patient access and increase physician’s prescribing of NATESTO® for the more than 13 million U.S. men diagnosed with hypogonadism."[/I][/B][/COLOR] Express Scripts serves more than 3,000 clients covering 70 million lives, including approximately 9 million lives managed by Cigna HealthCare. Drugs listed on formulary as preferred brands have been evaluated by the pharmacy benefit manager from a therapeutic and value perspective. [COLOR=rgb(184, 49, 47)][I][B]Preferred brand drugs may be available to patients at a lower co-pay or co-insurance than non-preferred brand drugs.[/B][/I][/COLOR] [/QUOTE]
Insert quotes…
Verification
Post reply
Share this page
Facebook
Twitter
Reddit
Pinterest
Tumblr
WhatsApp
Email
Share
Link
Sponsors
Forums
Testosterone Replacement, Low T, HCG, & Beyond
Testosterone and Men's Health Articles
Acerus Announces Significant Improvement in NATESTO® Insurance Coverage in the United States
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.
Accept
Learn more…
Top